Skip to content
drillr.ai
Sign up

603392.SH

万泰生物

SSE · Healthcare · Biotechnology · CN

CNY 28.09
−8.17%
Ask drillr

  • Aug 19, 2026, 08:28 UTC

    Wantai Biological announced its first-half 2026 results: revenue of 1.048 billion yuan, up 24.29% year-on-year, and a net loss attributable to shareholders of 128 million yuan, compared with a loss of 144 million yuan in the same period last year.

    Source:

  • Jul 3, 2026, 07:37 UTC

    Wantai Biological's director and general manager JIANG ZHIMING resigned on July 2, 2026, and chairman Qiu Zixin will temporarily assume the general manager duties.

    Source: